Edoardo Faggionato

Dr. Edoardo Faggionato

Department of Information Engineering - University of Padova
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
EFEdoardo Faggionato
Edoardo Faggionato
Michele SchiavonMichele Schiavon
Michele Schiavon
Chiara Dalla ManChiara Dalla Man
Chiara Dalla Man
Despite the great progress made in insulin preparation and titration, many patients with diabetes are still experiencing dangerous fluctuations in their blood glucose levels. This is mainly due to the large between- and within-subject variability, which considerably hampers insulin therapy, leading to defective dosing and timing of the administration process. In this work, we present a nonlinear mixed effects model describing the between-subject variability observed in the subcutaneous absorption of fast-acting insulin. A set of 14 different models was identified on a large and frequently-sampled database of lispro pharmacokinetic data, collected from 116 subjects with type 1 diabetes. The tested models were compared, and the best one was selected on the basis of the ability to fit the data, the precision of the estimated parameters, and parsimony criteria. The selected model was able to accurately describe the typical trend of plasma insulin kinetics, as well as the between-subject variability present in the absorption process, which was found to be related to the subject’s body mass index. The model provided a deeper understanding of the insulin absorption process and can be incorporated into simulation platforms to test and develop new open- and closed-loop treatment strategies, allowing a step forward toward personalized insulin therapy.

16 October 2023 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
EFEdoardo Faggionato
Edoardo Faggionato
Michele SchiavonMichele Schiavon
Michele Schiavon
LELaya Ekhlaspour
Laya Ekhlaspour
BBBruce A. Buckingham
Bruce A. Buckingham
Chiara Dalla ManChiara Dalla Man
Chiara Dalla Man
Objective: Modeling the effect of meal composition on glucose excursion would help in designing decision support systems (DSS) for type 1 diabetes (T1D) management. In fact, macronutrients differently affect post-prandial gastric retention (GR), rate of appearance (R $_\text{a}$ ), and insulin sensitivity (S $_\text{I}$ ). Such variables can be estimated, in inpatient settings, from plasma glucose (G) and insulin (I) data using the Oral glucose Minimal Model (OMM) coupled with a physiological model of glucose transit through the gastrointestinal tract (reference OMM, R-OMM). Here, we present a model able to estimate those quantities in daily-life conditions, using minimally-invasive (MI) technologies, and validate it against the R-OMM. Methods: Forty-seven individuals with T1D (weight $=78\pm$ 13 kg, age $=42\pm$ 10 yr) underwent three 23-hour visits, during which G and I were frequently sampled while wearing continuous glucose monitoring (CGM) and insulin pump (IP). Using a Bayesian Maximum A Posteriori estimator, R-OMM was identified from plasma G and I measurements, and MI-OMM was identified from CGM and IP data. Results: The MI-OMM fitted the CGM data well and provided precise parameter estimates. GR and R $_\text{a}$ model parameters were not significantly different using the MI-OMM and R-OMM (p $>$ 0.05) and the correlation between the two S $_\text{I}$ was satisfactory ( $\rho$ $=$ 0.77). Conclusion: The MI-OMM is usable to estimate GR, R $_\text{a}$ , and S $_\text{I}$ from data collected in real-life conditions with minimally-invasive technologies. Significance: Applying MI-OMM to datasets where meal compositions are available will allow modeling the effect of each macronutrient on GR, R $_\text{a}$ , and S $_\text{I}$ . DSS could finally exploit this information to improve diabetes management.

27 March 2023 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
EFEdoardo Faggionato
Edoardo Faggionato
AGAlessandro Guazzo
Alessandro Guazzo
Elena PegoloElena Pegolo
Elena Pegolo
RCRuggero Carli
Ruggero Carli
BMBruschetta Mattia
Bruschetta Mattia
SFSimone Del Favero
Simone Del Favero
Objective: Effective dosing of anticoagulants aims to prevent blood clot formation while avoiding hemorrhages. This complex task is challenged by several disturbing factors and drug-effect uncertainties, requesting frequent monitoring and adjustment. Biovariability in drug absorption and action further complicates titration and calls for individualized strategies. In this paper, we propose an adaptive closed-loop control algorithm to assist in warfarin therapy management. Methods: The controller was designed and tested in silico using an established pharmacometrics model of warfarin, which accounts for inter-subject variability. The control algorithm is an adaptive Model Predictive Control (a-MPC) that leverages a simplified patient model, whose parameters are updated with a Bayesian strategy. Performance was quantitatively evaluated in simulations performed on a population of virtual subjects against an algorithm reproducing medical guidelines (MG) and an MPC controller available in the literature (l-MPC). Results: The proposed a-MPC significantly (p $< $ 0.05) lowers rising time (2.8 vs. 4.4 and 11.2 days) and time out of range (3.3 vs. 7.2 and 12.9 days) with respect to both MG and l-MPC, respectively. Adaptivity grants a significantly (p $< $ 0.05) lower number of subjects reaching unsafe INR values compared to when this feature is not present (8.9% vs.15% of subjects presenting an overshoot outside the target range and 0.08% vs. 0.28% of subjects reaching dangerous INR values). Conclusion: The a-MPC algorithm improve warfarin therapy compared to the benchmark therapies. Significance: This in-silico validation proves effectiveness of the a-MPC algorithm for anticoagulant administration, paving the way for clinical testing.

29 March 2023 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
EFEdoardo Faggionato
Edoardo Faggionato
MLMarcello Laurenti
Marcello Laurenti
AVAdrian Vella
Adrian Vella
Chiara Dalla ManChiara Dalla Man
Chiara Dalla Man
Objective : To date, the lack of a model of glucagon kinetics precluded the possibility of estimating and studying glucagon secretion in vivo , e.g., using deconvolution, as done for other hormones like insulin and C-peptide. Here, we used a nonlinear mixed effects technique to develop a robust population model of glucagon kinetics, able to describe both the typical population kinetics (TPK) and the between-subject variability (BSV), and relate this last to easily measurable subject characteristics. Methods : Thirty-four models of increasing complexity (variably including covariates and correlations among random effects) were identified on glucagon profiles obtained from 53 healthy subjects, who received a constant infusion of somatostatin to suppress endogenous glucagon production, followed by a continuous infusion of glucagon (65 ng/kg/min). Model selection was performed based on its ability to fit the data, provide precise parameter estimates, and parsimony criteria. Results : A two-compartment model was the most parsimonious. The model was able to accurately describe both the TPK and the BSV of model parameters as function of body mass and body surface area. Parameters were precisely estimated, with central volume of distribution V1 = 5.46 L and peripheral volume of distribution V2 = 5.51 L. The introduction of covariates resulted in a significant shrinkage of the unexplained BSV and considerably improved the model fit. Conclusion : We developed a robust population model of glucagon kinetics. Significance : This model provides a deeper understanding of glucagon kinetics and is usable to estimate glucagon secretion in vivo by deconvolution of plasma glucagon concentration data.

1 March 2025 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
FBFederica Boscolo
Federica Boscolo
EFEdoardo Faggionato
Edoardo Faggionato
AWAndrew A. Welch
Andrew A. Welch
RFRahele A. Farahani
Rahele A. Farahani
AEAoife Egan
Aoife Egan
Chiara Dalla ManChiara Dalla Man
Chiara Dalla Man
In this study, we propose a new mathematical model able to quantify C-peptide secretion and β-cell responsivity in response to a glucagon bolus in individuals without and with type 2 diabetes. We show that individuals with type 2 diabetes exhibit reduced β-cell responsivity to glucagon.

24 April 2026 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
EFEdoardo Faggionato
Edoardo Faggionato
Michele SchiavonMichele Schiavon
Michele Schiavon
LELaya Ekhlaspour
Laya Ekhlaspour
RKRyan S. Kingman
Ryan S. Kingman
JSJennifer L. Sherr
Jennifer L. Sherr
Chiara Dalla ManChiara Dalla Man
Chiara Dalla Man
Background: Quantifying the effect of meal composition (MC) on postprandial glucose excursions would allow optimizing insulin therapy, accounting for fat and protein that can affect gastric retention (GR), glucose rate of appearance (R a ), and insulin sensitivity (S I ). Such variables can be estimated from continuous glucose monitor (CGM) and continuous subcutaneous insulin infusion (CSII) data using the Minimally-Invasive Oral Minimal Model (MI-OMM). In this work, we aim to quantify the effect of MC on those variables by applying the MI-OMM on a data set of prandial CGM and CSII profiles where MC information was available. Methods: A total of 120 individuals with type 1 diabetes (age = 15.5 ± 11.5 years, weight = 51.3 ± 28.0 kg) were monitored under free-living conditions while using CGM and CSII, and MC was carefully recorded. We extracted 353 CGM and CSII traces using predefined criteria and classified them into low or high fat content and low or high protein content. Finally, the MI-OMM was used to estimate GR, R a , and S I in each meal. Results: MI-OMM was able to fit CGM profiles and provided precise and physiologically plausible parameter estimates. Comparison among different classes of meals showed that a high content of fat and protein in the meal significantly slowed both GR ( P < .01) and R a ( P < .01), and reduced S I ( P < .05). Conclusions: In this work, the effect of MC on postprandial glucose excursion was quantified in real-life conditions with the help of a model-based methodology. These results are usable for redesigning current insulin therapies, accounting for the presence of fat and protein in meals.